Skip to main content
. 2022 Apr 6;12:858479. doi: 10.3389/fonc.2022.858479

Figure 2.

Figure 2

Molecular subtype and MDGPI score. (A) Venn plot showing the interaction of differentially expressed genes between tumor and normal samples in the TCGA and GEO datasets, and mitochondrial dysfunction-related genes; (B) forest plot showing genes associated with BCR-free survival in the TCGA database; (C) forest plot showing genes associated with BCR-free survival in the GSE116918 (17); (D) cluster plot showing distinct two groups in the TCGA database; (E) Kaplan–Meier curve presenting the BCR-free survival difference of the two clusters in the TCGA database; (F) cluster plot showing distinct two groups in the GSE116918 (17); (G) Kaplan–Meier curve presenting the BCR-free survival difference of the two clusters in the GSE116918 (17); (H) Kaplan–Meier curve presenting the metastasis-free survival difference of the two clusters in the GSE116918 (17); (I) Kaplan–Meier curve presenting the BCR-free survival difference of the high- and low-risk groups based on the median of MDGPI in the TCGA database; (J) Kaplan–Meier curve presenting the BCR-free survival difference of the high- and low-risk groups based on the median of MDGPI in the GSE116918 (17); (K) Kaplan–Meier curve presenting the metastasis-free survival difference of the high- and low-risk groups based on the median of MDGPI in the GSE116918 (17); (L) comparisons between cluster 2 and cluster 1 in the TCGA database for CXCL14, SFRP4, CD38, and MDGPI score; (M) comparisons between cluster 2 and cluster 1 in the GSE116918 (17) for CXCL14, SFRP4, CD38, and MDGPI score. BCR, biochemical recurrence; MDGPI, mitochondrial dysfunction-related genetic prognostic index. ***, p <0.001.